Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig islets

Clinical and Experimental Immunology

Volumn 162, Issue 3, 2010, Pages 537-542

  Valdes Gonzalez, R ^a,c   Rodriguez Ventura, A L ^a   White, D J G ^d   Bracho Blanchet, E ^b   Castillo, A ^a   Ramirez Gonzalez B ^a   Lopez Santos M G ^a   Leon Mancilla B H ^a,c   Dorantes, L M ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Chronic complications; Metabolic control; Porcine C peptide; Type 1 diabetes; Xenotransplantation

Indexed keywords

ARGININE; C PEPTIDE; HEMOGLOBIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCOSYLATION; HUMAN; IMMUNE DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MALE; METABOLIC REGULATION; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET CELL; PRIORITY JOURNAL; TRANSPLANTATION; URINALYSIS; ANIMAL; DIABETES MELLITUS; DISEASE COURSE; DISEASE FREE SURVIVAL; METABOLISM; NEWBORN; PANCREAS ISLET TRANSPLANTATION; PATHOPHYSIOLOGY; SWINE; TIME; URINE; XENOGRAFT;

ADOLESCENT; ANIMALS; ANIMALS, NEWBORN; C-PEPTIDE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 79951689321     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04273.x     Document Type: Article

References (35)

1. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care 2006; 29 (Suppl.1): S4-42.
2. DCCT/EDIC Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-53.
3. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291: 335-42.
4. Coppelli A, Giannarelli R, Vistoli F et al. The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care 2005; 28: 1366-70.
5. Luzi L, Perseghin G, Brendel MD et al. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 2001; 50:277-82.
6. Wahren J, Johansson BL, Wallberg-Henriksson H. Does C-peptide have a physiological role? Diabetología 1994 37 (Suppl. 2): S99-107 [Review].
7. Zhong Z, Kotova O, Davidescu A et al. C-peptide stimulates Na+, K+-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci 2004; 61:2782-90.
8. Rebsomen L, Pitel S, Boubred F et al. C-peptide replacement improves weight gain and renal function in dibetic rats. Diabetes Metab 2006; 32:223-8.
9. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren T. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med 2000; 17:181-9.
10. Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992; 35:121-8.
11. Christiansen JS, Frandsen M, Parving HH. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 1981; 20:199-204.
12. Elliott RB, Escobar L, Tan PL et al. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant Proc 2005; 37:3505-8.
13. Groth CG, Andersson A, Korsgren O et al. Transplantation of porcine fetal islet-like cell clusters into eight diabetic patients. Transplant Proc 1993; 25:970.
14. Toso C, Morel P, Bucher P et al. Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients. Transplantation 2003; 76:1133-4.
15. Matsumoto S, Okitsu T, Iwanaga Y et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 2005; 365:1642-4.
16. Shapiro A, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343:230-8.
17. Voltarelli JC, Couri CE, Stracieri AB et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007; 297:1568-76.
18. Valdes-Gonzalez RA, White DJG, Dorantes LM et al. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur J Endocrinol 2005; 153:419-27.
19. Valdés-González RA, White DJG, Dorantes LM et al. Three-year follow-up of a type 1 diabetes mellitus patient with an islet xenotransplant. Clin Trans 2007; 21:352-57.
20. Valdes-Gonzalez RA, Dorantes LM, Garibay GN et al. Unexpected immunoresponse to Gal and APA antigens in diabetic type 1 patients receiving neonatal pig islets after 6 years. J Clin Immunol 2007; 27:266-74.
21. Valdes-Gonzalez R, Dorantes LM, Bracho E, Rodriguez-Ventura A, White D. No evidence of porcine endogenous retrovirus in patients with type 1 diabetes after long term porcine islet xenotransplantation. J Med Virol 2010; 82:331-4.
22. Frolich-Reiterer EE, Ong KK, Regan F, Salzano G, Acerini CL, Dunger DB. A randomized cross-over trial to identify the optimal use of insulin glargine in prepubertal children using a three-times daily insulin regimen. Diabet Med 2007; 24:1406-11.
23. Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess 2004; 8:1-171. [Review]
24. Olsen BS, Johannesen J, Borch-Johnsen AK et al. Metabolic control and prevalence of microvascular complications in young Danish patients with type 1 diabetes mellitus. Diabet Med 1999; 16:79-85.
25. Donaghue KC, Craig ME, Chan AK et al. Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of child-hood diabetes. Diabet Med 2005; 22:711-18.
26. De Médeiros-Quenum M, Ndiaye PA, Cissé A et al. Epidemiological aspects of diabetic retinopathy in Senegal. J Fr Ophtalmol 2003; 26:160-3.
27. Ben Hamouda H, Messaoud R, Grira S et al. Prevalence and risk factors of diabetic retinopathy in children and young. J Fr Ophtalmol 2001; 24:367-70.
28. Groth CG, Tibell A, Wenneberg L, Korsgren O. Xenoislet transplantation: experimental and clinical aspects. J. Mol Med 1999; 77:153-4.
29. Elliot RB, Escobar L, Tan PL, Muzina M, Zwain S, Buchanan C. Live encapsulated porcine islets from a type 1 diabetic patient 9·5 yr after xenotransplantation. Xenotransplantation 2007; 14:157-61.
30. Valdes R, Cravioto MA, Tenopala J. Biological encapsulation as a new model for preservation of islets of Langerhans. Transplant Proc 1998; 30:481.
31. Valdés-González RA, Silva-Torres ML, Ramírez-González B, Terán L, Ormsby CE, Ayala-Sumuano JT. Improved method for isolation of porcine neonatal pancreatic cell clusters. Xenotransplantation 2005; 12:240-44.
32. Tatsuya K, Tatsuya G. Delayed functional maturation of neonatal porcine islets in recipients under strict glycemic control. Xenotransplantation 2007; 14:333-8.
33. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-53.
34. Barnett BP, Arepally A, Karmarkar PV et al. Magnetic resonance-guided, real time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med 2007; 13:986-91.
35. Balamurugan A, Nelson E, Ramakrishna B. Efect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats. Xenotransplantation 2007; 14:316-22.